Identification of a novel ovine PrP polymorphism and scrapie-resistant genotypes for St. Croix White and a related composite breedSeabury C.M. · Derr J.N.
Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station TX (USA)
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Susceptibility to scrapie is primarily controlled by polymorphisms in the ovine prion protein gene (PRNP). Here, we report a novel ovine exon three PRNP polymorphism (SNP G346C; P116), its association with the ovine ARQ allele (P116A136R154Q171), and two new genotypes (PARQ/ARR; PARQ/ARQ) for the St. Croix White (SCW) breed and a related composite (CMP) breed developed for meat production. The (P116) polymorphism occurs between the N-terminal cleavage site and the hydrophobic region of the ovine prion protein, a region which exhibits extreme conservation across mammalian taxa. The relatively high frequency (0.75) of resistant ARR alleles and the absence of ARQ alleles for the SCW ewes used as breeding stock for CMP resulted in significant genic differentiation (P = 0.0123; S.E. = 0.00113). Additionally, the majority of the SCW (66.7%) and CMP (65.4%) sampled possessed genotypes considered resistant or nearly resistant to scrapie and experimental BSE (bovine spongiform encephalopathy.
© 2003 S. Karger AG, Basel
- Arnold M, Meek C, Webb CR, Hoinville LJ: Assessing the efficacy of a ram-genotyping programme to reduce susceptibility to scrapie in Great Britain. Prev Vet Med 56:227–249 (2002).
Baylis M, Goldmann W, Houston F, Cairns D, Chong A, Ross A, Smith A, Hunter N, McLean AR: Scrapie epidemic in a fully PrP-genotyped sheep flock. J Gen Virol 83:2907–2914 (2002a).
Baylis M, Houston F, Kao RR, McLean AR, Hunter N, Gravenor MB: BSE-a wolf in sheep’s clothing? Trend Microbiol 10:563–570 (2002b).
- Belt PBGM, Muileman IH, Schreuder BEC, Ruijter JB, Gielkens ALJ, Smits MA: Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol 76:509–517 (1995).
- Bossers A, Schreuder B, Muileman I, Belt P, Smits M: PrP genotype contributes to determining survival times of sheep with natural scrapie. J Gen Virol 77:2669–2673 (1996).
- Bossers A, de Vries R, Smits M: Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 74:1407–1414 (2000).
- Cohen FE, Prusiner SB: Pathological conformations of prion proteins. A Rev Biochem 67:793–819 (1998).
Collinge J: Prion diseases of humans and animals: their causes and molecular basis. A Rev Neurosci 24:519–550 (2001).
- Dawson M, Hoinville LJ, Hosie BD, Hunter N: Guidance on the use of PrP genotyping as an aid to the control of clinical scrapie. Vet Rec 142:623–625 (1998).
- Foster JD, Parnham D, Chong A, Goldmann W, Hunter N: Clinical Signs, histopathology and genetics of experimental transmission of BSE and natural scrapie to sheep and goats. Vet Rec 148:165–171 (2001).
Godfrey RW, Collins JR: Post-weaning growth and carcass traits of hair and wool × hair lambs in the US Virgin Islands. Sheep Goat Res J 15:100–105 (1999).
Harris DA, Huber MT, van Dijken P, Shyng S-L, Chait BT, Wang R: Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochem 32:1009–1016 (1993).
Hunter N: Molecular Biology and genetics of scrapie in sheep, in Piper L, Ruvinsky A (eds): The Genetics of Sheep, pp 225–240 (CAB International, Wallingford 1997).
- Hunter N, Foster JD, Goldmann W, Stear MJ, Hope J, Bostock C: Natural scrapie in a closed flock of Cheviot sheep occurs only in specific PrP genotypes. Arch Virol 141:809–824 (1996).
- Jeffrey M, Ryder S, Martin S, Hawkins SAC, Terry L, Berthelin-Baker C, Bellworthy SJ: Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol 124:280–289 (2001).
Mazzola V: St. Croix sheep resist worms. Agricult Res Oct. p. 27 (1990).
- O’Rourke KI, Melco RP, Mickelson JR: Allelic frequencies of an ovine scrapie susceptibility gene. Anim Biotech 7:155–162 (1996).
- O’Rourke KI, Holyoak GR, Clark WW, Mickelson JR, Wang S, Melco RP, Besser TE, Foote WC: PrP genotypes and experimental scrapie in orally inoculated Suffolk sheep in the United States. J Gen Virol 78:975–978 (1997).
- O’Rourke KI, Duncan JV, Logan JR, Anderson AK, Norden DK, Williams ES, Combs BA, Stobart RH, Moss GE, Sutton DL: Active surveillance for scrapie by third eyelid biopsy and genetic susceptibility testing of flocks of sheep in Wyoming. Clin Diagn Lab Immun 9:966–971 (2002).
- Prusiner SB, Füzi M, Scott M, Serban D, Serban H, Taraboulos A, Gabriel JM, Wells GAH, Wilesmith JW, Bradley R, DeArmond SJ, Kristensson K: Immunologic and molecular biologic studies of prion proteins in bovine spongiform encephalopathy. J Infect Dis 167:602–613 (1993).
Raymond M, Rousset F: GENEPOP (Version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86:248–249 (1995).
- Sabuncu E, Petit S, Dur AL, Lai TL, Vilotte JL, Laude H, Vilette D: PrP polymorphisms tightly control sheep prion replication in cultured cells. J Virol 77:2696–2700 (2003).
Shelton M: Hair sheep production under temperate and tropical conditions, in Wildeus S (ed): Hair Sheep Research Symposium, pp 65–84 (USVI, St. Croix 1991).
- van Rheede T, Smolenaars MW, Madsen O, de Jong WW: Molecular evolution of the mammalian prion protein. Mol biol Evol 20:111–121 (2003).
- Westaway D, Zuliani V, Cooper C, Da Costa M, Neuman S, Jenny AL, Detwiler L, Prusiner SB: Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev 8:959–969 (1994).
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.